Plasma Levels of Soluble Receptor for Advanced Glycation End Products and Coronary Atherosclerosis: Possible Correlation with Clinical Presentation

Table 1

Demographic, clinical, and biochemical characteristics of the studied population.

	Myocardial infarction patients; (𝑛=183)	Unstable angina patients; (𝑛=147)	Stable angina patients; (𝑛=530)	𝑃 value
Age, y	59.9 ± 5.7	60.6 ± 7.1	64 ± 10	𝑃<0.01
Male, 𝑛 (%)	146 (80%)	109 (74%)	428 (81%)	Ns
BMI, kg/m^2	27 ± 3	28 ± 3	27 ± 5	Ns
Total cholesterol	190 ± 38	192 ± 41	189 ± 40	Ns
Triglycerides	148 ± 51	155 ± 49	152 ± 54	Ns
HDL cholesterol	49 ± 19	45 ± 23	48 ± 22	Ns
Hypertension, 𝑛 (%)	126 (69%)	94 (64%)	334 (63%)	Ns
Diabetes, 𝑛 (%)	37 (20%)	37 (25%)	151 (28%)	Ns
Dyslipidemia, 𝑛 (%)	123 (67%)	91 (61%)	434 (82%)	𝑃<0.01
Ever smoking, 𝑛 (%)	106 (58%)	82 (56%)	314 (59%)	Ns
Creatinine, mg/dL	0.9 ± 0.3	1 ± 0.1	1.1 ± 0.5	Ns
Hemoglobin, g/L	12.9 ± 1.7	13.5 ± 1.4	12.3 ± 2.5	Ns
sRAGE, pg/mL	584 (266–851)	769 (394–987)	834 (630–1005)	𝑃<0.001